↓ Skip to main content

The Cost Effectiveness and Cost Utility of Valsartan in Chronic Heart Failure Therapy in Italy

Overview of attention for article published in American Journal of Cardiovascular Drugs, August 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (84th percentile)
  • High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

policy
3 policy sources

Citations

dimensions_citation
12 Dimensions

Readers on

mendeley
41 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The Cost Effectiveness and Cost Utility of Valsartan in Chronic Heart Failure Therapy in Italy
Published in
American Journal of Cardiovascular Drugs, August 2012
DOI 10.2165/11315730-000000000-00000
Pubmed ID
Authors

Lorenzo Pradelli, Sergio Iannazzo, Orietta Zaniolo

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 41 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Germany 1 2%
Unknown 40 98%

Demographic breakdown

Readers by professional status Count As %
Researcher 9 22%
Student > Master 8 20%
Student > Ph. D. Student 6 15%
Student > Bachelor 4 10%
Other 2 5%
Other 2 5%
Unknown 10 24%
Readers by discipline Count As %
Medicine and Dentistry 7 17%
Economics, Econometrics and Finance 7 17%
Nursing and Health Professions 3 7%
Pharmacology, Toxicology and Pharmaceutical Science 3 7%
Decision Sciences 2 5%
Other 9 22%
Unknown 10 24%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 December 2015.
All research outputs
#3,890,630
of 25,830,005 outputs
Outputs from American Journal of Cardiovascular Drugs
#78
of 477 outputs
Outputs of similar age
#26,341
of 187,953 outputs
Outputs of similar age from American Journal of Cardiovascular Drugs
#11
of 128 outputs
Altmetric has tracked 25,830,005 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 477 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.7. This one has done well, scoring higher than 82% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 187,953 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 84% of its contemporaries.
We're also able to compare this research output to 128 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.